These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1008547)

  • 1. Antibiotic synergy and antagonism against clinical isolates of Klebsiella species.
    D'Alessandri RM; McNeely DJ; Kluge RM
    Antimicrob Agents Chemother; 1976 Dec; 10(6):889-92. PubMed ID: 1008547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro synergistic effect of netilmicin, a new aminoglycoside antibiotic.
    Fu KP; Neu HC
    Antimicrob Agents Chemother; 1976 Sep; 10(3):511-8. PubMed ID: 791104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of carbenicillin - aminoglycoside and of cephalothin-aminoglycoside combinations against enterococci in vitro.
    Klastersky J; Daneau D
    Pathol Biol (Paris); 1975 May; 23(5):345-8. PubMed ID: 1105331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colistin-sparing regimens against Klebsiella pneumoniae carbapenemase-producing K. pneumoniae isolates: Combination of tigecycline or doxycycline and gentamicin or amikacin.
    Tang HJ; Lai CC; Chen CC; Zhang CC; Weng TC; Chiu YH; Toh HS; Chiang SR; Yu WL; Ko WC; Chuang YC
    J Microbiol Immunol Infect; 2019 Apr; 52(2):273-281. PubMed ID: 27133391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of minocycline combined with aminoglycosides against Klebsiella pneumoniae carbapenemase-producing K. pneumoniae.
    Wentao N; Guobao L; Jin Z; Junchang C; Rui W; Zhancheng G; Youning L
    J Antibiot (Tokyo); 2018 May; 71(5):506-513. PubMed ID: 29416121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newer aminoglycosides--amikacin and tobramycin: an in-vitro comparison with kanamycin and gentamicin.
    Reynolds AV; Hamilton-Miller JM; Brumfitt W
    Br Med J; 1974 Sep; 3(5934):778-80. PubMed ID: 4213265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the susceptibility of 150 consecutive clinical isolates of Pseudomonas aeruginosa to tobramycin, gentamicin, colistin, carbenicillin, and five other antimicrobials.
    Lockwood WR; Lawson LA
    Antimicrob Agents Chemother; 1973 Sep; 4(3):281-4. PubMed ID: 4202342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sensitivity of Klebsiella to antibiotics. Study of 50 strains from cases of "extra" and "intrahospital" septicemia].
    Trolin C; Schoutens E; Yourassowsky E
    Pathol Biol (Paris); 1973 Jun; 21(6):581-5. PubMed ID: 4581191
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro susceptibility of cephalothin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to Amikacin and selected new beta-lactam agents.
    McNamara BT; Meyer RD; Pasiecznik KA
    Antimicrob Agents Chemother; 1982 May; 21(5):753-7. PubMed ID: 6213196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro effectiveness of kanamycin and kanamycin/cephalothin against Klebsiella. Comparison with other antibiotics.
    Bulger RJ
    Ann Intern Med; 1967 Sep; 67(3):523-32. PubMed ID: 6042642
    [No Abstract]   [Full Text] [Related]  

  • 11. Antimicrobial effectiveness ofkanamycin, aminosidin, BB-K8, sisomicin, gentamicin and tobramycin combined with carbenicillin or cephalothin against gram-negative rods.
    Klastersky J; Nyamubeya B; Vandenborre L
    J Med Microbiol; 1974 Nov; 7(4):465-72. PubMed ID: 4217836
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative susceptibilities of clinical isolates of Serratia marcescens to newer cephalosporins, alone and in combination with various aminoglycosides.
    Markowitz SM; Sibilla DJ
    Antimicrob Agents Chemother; 1980 Nov; 18(5):651-5. PubMed ID: 7004344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic sensitivity of Klebsiella-Enterobacter.
    Russell JP
    Am J Clin Pathol; 1969 Mar; 51(3):384-9. PubMed ID: 4885298
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro activity of sisomicin, an aminoglycoside antibiotic, against clinical isolates.
    Stewart D; Bodey GP
    J Antibiot (Tokyo); 1975 Feb; 28(2):149-55. PubMed ID: 234415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergy of azlocillin and mezlocillin combined with aminoglycoside antibiotics and cephalosporins.
    Neu HC; Fu KP
    Antimicrob Agents Chemother; 1978 May; 13(5):813-9. PubMed ID: 666302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibacterial activity of selected beta-lactam and aminoglycoside antibiotics against cephalothin-resistant Enterobacteriaceae.
    Lewis RP; Meyer RD; Kraus LL
    Antimicrob Agents Chemother; 1976 May; 9(5):780-6. PubMed ID: 949175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of non-lactose-fermenting members of the Klebsiella-Enterobacter-Serratia division. II. Antibiotic susceptibility.
    Oberhofer TR; Hajkowski R
    Am J Clin Pathol; 1970 Nov; 54(5):726-32. PubMed ID: 4319856
    [No Abstract]   [Full Text] [Related]  

  • 18. Increased minimum inhibitory concentrations with anaerobiasis for tobramycin, gentamicin, and amikacin, compared to latamoxef, piperacillin, chloramphenicol, and clindamycin.
    Tack KJ; Sabath LD
    Chemotherapy; 1985; 31(3):204-10. PubMed ID: 3888545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro susceptibility of gentamicin and/or tobramycin resistant gram-negative bacilli to seven aminoglycosides.
    Watanakunakorn C; Kauffman CA
    Infection; 1978; 6(3):111-5. PubMed ID: 98451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility of current clinical isolates of Pseudomonas aeruginosa and enteric gram-negative bacilli to amikacin and other aminoglycoside antibiotics.
    Dámaso D; Moreno-López M; Martínez-Beltrán J; García-Iglesias MC
    J Infect Dis; 1976 Nov; 134 SUPPL():S394-90. PubMed ID: 825591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.